| Autor: |
Izadi, Mahmoud, Sadr Hashemi Nejad, Anavasadat, Moazenchi, Maedeh, Masoumi, Safdar, Rabbani, Ali, Kompani, Farzad, Hedayati Asl, Amir Abbas, Abbasi Kakroodi, Fatemeh, Jaroughi, Neda, Mohseni Meybodi, Mohammad Ali, Setoodeh, Aria, Abbasi, Farzaneh, Hosseini, Seyedeh Esmat, Moeini Nia, Fatemeh, Salman Yazdi, Reza, Navabi, Roghayeh, Hajizadeh-Saffar, Ensiyeh, Baharvand, Hossein |
| Rok vydání: |
2022 |
| DOI: |
10.6084/m9.figshare.20105559.v1 |
| Popis: |
Additional file 1: Table S1. Materials used in this study. Table S2. Analysis of the carryover effect. Table S3. List of follow up events. Table S4. Complete list of assessed adverse events. Table S5. Comparison of metabolic indices in a 12-month follow-up of mesenchymal stem cells (MSCs) versus placebo. Table S6. Comparison of immunologic indices in 12 months follow-up of MSCs versus placebo. Table S7. Comparing the quality of life (QOL) questionnaires scores in 12 months follow-up of MSCs versus Placebo. Table S8. Comparison of quality of life (QOL) questionnaire scores in 12 months of follow-up between the early (Early Tx) and late (Late Tx) transplantation groups. Table S9. Comparison of metabolic indices in 12 months of follow-up between early versus late transplantation of MSCs. Table S10. Comparison of immunologic indices in 12 months of follow-up for the early (Early Tx) and late (Late Tx) transplantation groups. Figure S1. Sample of cytogenetic report of MSCs. Figure S2. Sample of microbiological and bacterial endotoxin report. Figure S3. Sample of mycoplasma report. Figure S4. Flow Cytometric Analysis of Mesenchymal Stem Cells. Figure S5. Mesenchymal Stem Cells (MSCs) morphology and differentiation potential |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
